184 related articles for article (PubMed ID: 16847114)
1. Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein.
Kang H; Kim ET; Lee HR; Park JJ; Go YY; Choi CY; Ahn JH
J Gen Virol; 2006 Aug; 87(Pt 8):2181-2190. PubMed ID: 16847114
[TBL] [Abstract][Full Text] [Related]
2. Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells.
Lee HR; Kim DJ; Lee JM; Choi CY; Ahn BY; Hayward GS; Ahn JH
J Virol; 2004 Jun; 78(12):6527-42. PubMed ID: 15163746
[TBL] [Abstract][Full Text] [Related]
3. Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.
Xu Y; Ahn JH; Cheng M; apRhys CM; Chiou CJ; Zong J; Matunis MJ; Hayward GS
J Virol; 2001 Nov; 75(22):10683-95. PubMed ID: 11602710
[TBL] [Abstract][Full Text] [Related]
4. The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.
Schilling EM; Scherer M; Reuter N; Schweininger J; Muller YA; Stamminger T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903803
[TBL] [Abstract][Full Text] [Related]
5. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.
Ahn JH; Hayward GS
J Virol; 1997 Jun; 71(6):4599-613. PubMed ID: 9151854
[TBL] [Abstract][Full Text] [Related]
6. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
7. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML.
Ahn JH; Brignole EJ; Hayward GS
Mol Cell Biol; 1998 Aug; 18(8):4899-913. PubMed ID: 9671498
[TBL] [Abstract][Full Text] [Related]
8. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.
Ahn JH; Hayward GS
Virology; 2000 Aug; 274(1):39-55. PubMed ID: 10936087
[TBL] [Abstract][Full Text] [Related]
9. N-terminal determinants of human cytomegalovirus IE1 protein in nuclear targeting and disrupting PML-associated subnuclear structures.
Lee HR; Huh YH; Kim YE; Lee K; Kim S; Ahn JH
Biochem Biophys Res Commun; 2007 May; 356(2):499-504. PubMed ID: 17367754
[TBL] [Abstract][Full Text] [Related]
10. Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.
Hou W; Cruz-Cosme R; Wen F; Ahn JH; Reeves I; Luo MH; Tang Q
J Virol; 2018 Dec; 92(23):. PubMed ID: 30258013
[TBL] [Abstract][Full Text] [Related]
11. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10).
Ahn JH; Jang WJ; Hayward GS
J Virol; 1999 Dec; 73(12):10458-71. PubMed ID: 10559364
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human herpesvirus 6 variant B immediate-early 1 protein modifications by small ubiquitin-related modifiers.
Gravel A; Dion V; Cloutier N; Gosselin J; Flamand L
J Gen Virol; 2004 May; 85(Pt 5):1319-1328. PubMed ID: 15105549
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.
Tavalai N; Papior P; Rechter S; Leis M; Stamminger T
J Virol; 2006 Aug; 80(16):8006-18. PubMed ID: 16873257
[TBL] [Abstract][Full Text] [Related]
14. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
Adamson AL; Kenney S
J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
[TBL] [Abstract][Full Text] [Related]
15. The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction.
Ohbayashi N; Kawakami S; Muromoto R; Togi S; Ikeda O; Kamitani S; Sekine Y; Honjoh T; Matsuda T
Biochem Biophys Res Commun; 2008 Jul; 371(4):823-8. PubMed ID: 18474224
[TBL] [Abstract][Full Text] [Related]
16. SUMO-1 protease-1 regulates gene transcription through PML.
Best JL; Ganiatsas S; Agarwal S; Changou A; Salomoni P; Shirihai O; Meluh PB; Pandolfi PP; Zon LI
Mol Cell; 2002 Oct; 10(4):843-55. PubMed ID: 12419228
[TBL] [Abstract][Full Text] [Related]
17. Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product.
Wilkinson GW; Kelly C; Sinclair JH; Rickards C
J Gen Virol; 1998 May; 79 ( Pt 5)():1233-45. PubMed ID: 9603339
[TBL] [Abstract][Full Text] [Related]
18. Small ubiquitin-related modifier (SUMO) pathway-mediated enhancement of human cytomegalovirus replication correlates with a recruitment of SUMO-1/3 proteins to viral replication compartments.
Scherer M; Reuter N; Wagenknecht N; Otto V; Sticht H; Stamminger T
J Gen Virol; 2013 Jun; 94(Pt 6):1373-1384. PubMed ID: 23407422
[TBL] [Abstract][Full Text] [Related]
19. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption.
Müller S; Dejean A
J Virol; 1999 Jun; 73(6):5137-43. PubMed ID: 10233977
[TBL] [Abstract][Full Text] [Related]
20. The SUMO protease SENP6 is a direct regulator of PML nuclear bodies.
Hattersley N; Shen L; Jaffray EG; Hay RT
Mol Biol Cell; 2011 Jan; 22(1):78-90. PubMed ID: 21148299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
